InvestorsObserver is giving Clovis Oncology Inc (CLVS) an Analyst Rating Rank of 0, meaning CLVS is ranked higher by analysts than 0% of stocks. The average price target for CLVS is $2 and analyst’s rate the stock as a Sell.
Wall Street analysts are rating CLVS a Sell today. Find out what this means to you and get the rest of the rankings on CLVS!